Provided by Tiger Fintech (Singapore) Pte. Ltd.

California Resources

35.68
+1.053.03%
Post-market: 35.680.00000.00%16:07 EDT
Volume:528.67K
Turnover:18.86M
Market Cap:3.23B
PE:7.72
High:36.08
Open:35.03
Low:35.03
Close:34.63
Loading ...

Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week

Insider Monkey
·
23 Jan

Hold Rating on Exelixis: Early Phase 1 CRC Trial Data Shows Promise but Raises Uncertainties

TIPRANKS
·
22 Jan

Natera to Present New Data at the 2025 ASCO GI Symposium

Business Wire
·
22 Jan

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

PR Newswire
·
22 Jan

Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test

Benzinga
·
22 Jan

Guardant Health Gets Medicare Coverage for Guardant Reveal in CRC Surveillance Testing

MT Newswires Live
·
21 Jan

Analysts Offer Insights on Energy Companies: California Resources Corp (CRC) and Conocophillips (COP)

TIPRANKS
·
21 Jan

Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)

CNW Group
·
20 Jan

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

PR Newswire
·
17 Jan

California Resources Corporation Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

GlobeNewswire
·
15 Jan

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection

Business Wire
·
15 Jan

California Resources Corp: Strategic Growth and Value Creation Through Carbon Capture and Sustainable Energy Initiatives

TIPRANKS
·
15 Jan

California Resources Price Target Maintained With a $70.00/Share by RBC Capital

Dow Jones
·
15 Jan

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

GlobeNewswire
·
14 Jan

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market

Benzinga
·
14 Jan

BofA Adjusts Price Target on California Resources to $64 From $65, Keeps Buy Rating

MT Newswires Live
·
13 Jan

California Resources Initiated at Buy by Truist Securities

Dow Jones
·
13 Jan

California Resources Corp : Truist Securities Initiates Coverage With Buy Rating; Price Target $75

THOMSON REUTERS
·
13 Jan

Truist Initiates California Resources at Buy With $75 Price Target

MT Newswires Live
·
13 Jan

Press Release: Exelixis Announces Preliminary Fiscal Year 2024 Financial Results, Provides 2025 Financial Guidance and Outlines Key Priorities and Milestones for 2025

Dow Jones
·
13 Jan